On 25 February, Orexigen Therapeutics, Inc. (NASDAQ:OREX) reported a net loss of $37.5 million, or $0.32 per share, as compared to a net loss of $77.7 million, or $0.80 per share, for 2013. Total operating expenses for 2014 were $86.1 million compared to $80.6 million for 2013. On Tuesday shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX) closed at $7.64. Company’s sales growth for last 5 years was 102.40% and EPS growth for next 5 years is recorded as 20.00%.
McDermott International, Inc. (NYSE:MDR) announced that it has been awarded a large project for a new jacket, temporary deck and replacement umbilical by Qatar Petroleum for the North Field Alpha gas development, offshore Qatar. Work is expected to be executed through the second quarter of 2016 and will be included in McDermott’s first quarter 2015 backlog. McDermott International Inc. (NYSE:MDR) in last trading activity moved up 27.59% to close at $3.33. Company weekly performance is 31.62% while its quarterly performance stands at -6.20%. McDermott International Inc. (NYSE:MDR) is -60.59% away from its 52 week high.
The Middleby Corporation (NASDAQ: MIDD), reported net sales and earnings for the fourth quarter and full fiscal year ended January 3, 2015. Net earnings for the fourth quarter were $51,749,000 or $0.91 diluted earnings per share on net sales of $434,995,000 as compared to the prior year fourth quarter net earnings of $49,921,000 or $0.87 diluted earnings per share on net sales of $377,420,000. On last trading day Middleby Corp. (NASDAQ:MIDD) fell -0.68% to close at $106.89. Its volatility for the week is 2.11% while volatility for the month is 2.30%. MIDD’s sales growth for past 5 years was 17.00% and its EPS growth for past 5 years was 17.00%. Middleby Corp. (NASDAQ:MIDD) monthly performance is 12.49%.
Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) announced it has entered into a line of credit agreement with Webster Business Credit Corporation pursuant to which the lender has agreed to advance up to $14 million at an interest rate of either LIBOR plus 4.75% or Prime plus $3.25% against assignments of mortgages and other collateral. Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) has 1.20% insider ownership while its institutional ownership stands at 2.20%. In last trading activity company’s stock closed at $3.65.
Identiv, Inc. (NASDAQ: INVE), announced it will report financial results for the fourth quarter and fiscal year ended December 31, 2014 on Thursday, March 12, 2015 after close of market. Identiv will host a conference call and audio webcast to discuss the results at 2:00 PM PT (5:00 PM ET). On last trading day Identiv, Inc. (NASDAQ:INVE) moved up 1.42% to close at $10.00. Its volatility for the week is 8.16% while volatility for the month is 5.71%. INVE’s sales growth for past 5 years was 21.60% and its EPS growth for past 5 years was 11.60%. Identiv, Inc. (NASDAQ:INVE) monthly performance is -20.70%.